Dov Pharmaceutical's IPO

Dov Pharmaceutical raised a round of funding on April 21, 2004. Investors include Public.

focuses on novel drug candidates for central nervous system and other disorders, including cardiovascular and urological, that involve alterations in neuronal processing. Insomnia, pain and anxiolytic…

Articles about Dov Pharmaceutical's IPO: